Structures by: Sankari S.
Total: 8
4-(4-Chlorophenyl)-1,2,3-selenadiazole
C8H5ClN2Se
IUCrData (2018) 3, 3 x180462
a=10.3353(9)Å b=14.0058(12)Å c=5.9540(4)Å
α=90° β=97.320(3)° γ=90°
5-[1-(4-Methoxyphenyl)-2-nitrobutyl]-4-phenyl-1,2,3-selenadiazole
C19H19N3O3Se
Acta Crystallographica Section E (2012) 68, 6 o1784
a=8.3072(5)Å b=8.5468(5)Å c=13.6969(9)Å
α=81.293(3)° β=79.670(3)° γ=78.888(3)°
Ethyl 2-phenyl-3-(4-phenyl-1,2,3-selenadiazol-5-yl)-3-<i>p</i>-tolylpropanoate
C26H24N2O2Se
Acta Crystallographica Section E (2012) 68, 2 o447
a=12.148(5)Å b=12.333(5)Å c=16.522(5)Å
α=90.00° β=108.768(5)° γ=90.00°
4-(5-Chlorothiophen-2-yl)-1,2,3-selenadiazole
C6H3ClN2SSe
Acta Crystallographica Section E (2013) 69, 1 o65
a=6.0412(3)Å b=19.5870(11)Å c=7.2010(4)Å
α=90.00° β=110.257(3)° γ=90.00°
5-(2-Nitro-1-phenylbutyl)-4-phenyl-1,2,3-selenadiazole
C18H17N3O2Se
Acta Crystallographica Section E (2012) 68, 3 o871
a=7.879(5)Å b=8.450(5)Å c=13.438(5)Å
α=80.629(5)° β=85.273(5)° γ=75.352(5)°
Ethyl 3-(4-methoxyphenyl)-2-phenyl-3-(4-phenyl-1,2,3-selenadiazol-5-yl)propanoate
C26H24N2O3Se
Acta Crystallographica Section E (2012) 68, 8 o2347
a=11.8187(4)Å b=12.8241(5)Å c=16.1837(6)Å
α=90.00° β=105.280(2)° γ=90.00°
5-[1-(4-Methylphenyl)-2-nitrobutyl]-4-phenyl-1,2,3-selenadiazole
C19H19N3O2Se
Acta Crystallographica Section E (2013) 69, 3 o430
a=8.2088(5)Å b=8.4755(5)Å c=13.7031(8)Å
α=80.669(3)° β=81.832(3)° γ=76.681(3)°
Ethyl 3-(4-chlorophenyl)-2-phenyl-3-(4-phenyl-1,2,3-selenadiazol-5-yl)propanoate
C25H21ClN2O2Se
Acta Crystallographica Section E (2013) 69, 8 o1239
a=12.1337(3)Å b=12.2267(3)Å c=16.4423(4)Å
α=90.00° β=107.7440(10)° γ=90.00°